Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070627 · ClinicalTrials.gov registry record · Phase 1
Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study
A Phase 1 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT02070627 is a Phase 1 study that has completed, run by Ohio State University. The registered enrollment target is 6 participants.
The verdict
NCT02070627, a Phase 1 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate an imaging system using Indocyanine Green (ICG) to assist in real-time identification of anatomy during cholecystectomy (gallbladder removal) in patients with acute cholecystitis and cholangitis. We propose to define the effectiveness of NIRF-C in identifying the cystic duct junction during cholecystectomy.
Interventions
- DRUG Indocyanine Green (ICG)
- DEVICE Near Infrared Fluorescence Cholangiography (NIRF-C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02070627
The ClinicalTrials.gov registry entry for NCT02070627 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indocyanine Green (ICG) is the first listed.
NCT02070627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02070627 about?
NCT02070627 is a clinical study titled "Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study". The purpose of this study is to evaluate an imaging system using Indocyanine Green (ICG) to assist in real-time identification of anatomy during cholecystectomy (gallbladder removal) in patients with acute cholecystitis and cholangitis. We propose to define the effectiveness of NIRF-C in identifying...
What is the current status of trial NCT02070627?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2013-07. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02070627?
The interventions under investigation include: Indocyanine Green (ICG) (DRUG), Near Infrared Fluorescence Cholangiography (NIRF-C) (DEVICE).
Who is sponsoring clinical trial NCT02070627?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.